- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/18 - Benzotriazoles
Patent holdings for IPC class C07D 249/18
Total number of patents in this class: 363
10-year publication summary
|
24
|
24
|
28
|
16
|
25
|
21
|
21
|
20
|
18
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 453 |
27 |
| Merck Patent GmbH | 5752 |
9 |
| Alcon, Inc. | 5535 |
7 |
| Vectus Biosystems Limited | 31 |
7 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
6 |
| Amgen Inc. | 4256 |
5 |
| Astex Therapeutics Limited | 231 |
5 |
| VALO Health, Inc. | 176 |
5 |
| NRG Therapeutics Ltd | 14 |
5 |
| Bayer Pharma AG | 1048 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
4 |
| Ecolab USA Inc. | 5601 |
4 |
| Theravance, Inc. | 65 |
4 |
| Trinapco, Inc. | 19 |
4 |
| University of Tennessee Research Foundation | 756 |
4 |
| Merck Sharp & Dohme LLC | 3732 |
4 |
| Novartis AG | 10612 |
3 |
| BASF SE | 21098 |
3 |
| LG Chem, Ltd. | 17706 |
3 |
| Takeda Pharmaceutical Company Limited | 2721 |
3 |
| Other owners | 247 |